Release of CM ‐12 from A2 ‐type casein by the cleavage of Ser–Leu–Xaa at the C‐terminus using Aspergillus oryzae alkaline protease
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2024. Verfasst von Cui Yingjie und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan. Hauptthemen laut MEDLINE: Aspergillus oryzae, Caseins, Endopeptidases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Aspergillus oryzae protease can release the opioid peptide β‐casomorphin‐10 (CM‐10, YPFPGPIPNS, 60–69) from A2‐type casein. However, not only is the yield of the active peptide low, but the key enzyme involved in processing has yet to be identified. RESULTS A significant amount of the opioid peptide 60 YPFPGPIPNSLP 71 (CM‐12) was produced from the A2‐type casein peptide 53 AQTQSLVYPFPGPIPNSLPQNIPPLTQTPV 82 when the active protease in A. oryzae protease extract was fractionated with DEAE‐Sepharose. The fractionated enzyme produced CM‐12 from bovine A2‐type casein but not from bovine A1 casein. A major protein of 34 kDa was purified and identified as an alkaline protease (Alp). Motif prediction of the Alp cleavage site using Multiple EM for Motif Elicitation analysis revealed preferable cleavage at the C‐terminal end of Ser–Leu–Xaa for the release of CM‐12. A2‐type casein hydrolysate by Alp exhibited similar levels of opioid activity to that of synthetic CM‐12 in cAMP‐Glo assays with μ‐opioid receptor‐expressing HEK293 cells. These results suggest that CM‐12 is a major opioid peptide in the casein hydrolysate. CONCLUSION Our findings showed that Alp fractionated from A. oryzae protease extract produced the opioid peptide CM‐12 from A2‐type casein as a result of preferential cleavage at the C‐terminal end of Ser–Leu–Xaa and the removal of coexisting enzymes. Moreover, docking predictions suggested a stable interaction between CM‐12 and the 3D structure of Alp. Casein hydrolysate with Alp‐containing CM‐12 has the potential for use as a bioactive peptide material with opioid activity. © 2024 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
- Department of Life Science and Technology, Graduate School of Life Science and Technology, Tokyo Institute of Technology, Tokyo, Japan.
- Department of Infection and Immunity, School of Medicine, Jichi Medical University, Tochigi, Japan.
ORCID-Profile: Naoyuki Yamamoto
Zitieren
APA
Yingjie, C., Fukunaga, M., Hayashi, N., Orihara, K., Miyanaga, K., & Yamamoto, N. (2024). Release of CM ‐12 from A2 ‐type casein by the cleavage of Ser–Leu–Xaa at the C‐terminus using Aspergillus oryzae alkaline protease. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13743
Vancouver
Yingjie C, Fukunaga M, Hayashi N, Orihara K, Miyanaga K, Yamamoto N. Release of CM ‐12 from A2 ‐type casein by the cleavage of Ser–Leu–Xaa at the C‐terminus using Aspergillus oryzae alkaline protease. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13743
BibTeX
@article{Yingjie2024,
author = {Yingjie, Cui and Fukunaga, Moe and Hayashi, Nobuhiro and Orihara, Kanami and Miyanaga, Kazuhiko and Yamamoto, Naoyuki},
title = {Release of CM ‐12 from A2 ‐type casein by the cleavage of Ser–Leu–Xaa at the C‐terminus using Aspergillus oryzae alkaline protease},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13743}
}
EUVIMED